Employing Chest CT Imaging for Diagnosing and Managing COVID-19 Infections in Emergency Intensive Care Settings

By
Linling Chen
Yongjia Wu
June 5, 2026

Frontiers In Medicine

Overview

This study evaluates the diagnostic validity of chest CT imaging in symptomatic COVID-19 patients when RT-PCR is unavailable. Findings indicate that chest CT is a crucial tool for early detection and management of COVID-19, particularly within 5 days of symptom onset.

Background

The COVID-19 pandemic has created significant challenges in diagnosis, especially when RT-PCR testing is limited. Accurate and timely diagnosis is essential for effective infection control and resource allocation in emergency and intensive care settings. Chest CT imaging has emerged as a valuable adjunct diagnostic tool, particularly in situations where RT-PCR results are delayed or unavailable.

Data Highlights

Parameter	Value
Mean Age	67.2 years
Male Percentage	64.9%
Common CT Finding	Ground-glass opacity (56.8%)

Key Findings

Chest CT demonstrated high sensitivity compared to RT-PCR for diagnosing COVID-19.
Ground-glass opacity (GGO) was the most common finding, observed in 56.8% of patients.
CT severity levels were higher in patients, indicating its role in predicting disease severity.
Two distinct CT phenotypes were identified among the patient group.
Prompt CT examinations within 5 days of symptom onset improved diagnostic precision.

Clinical Implications

Chest CT can serve as an important diagnostic tool in emergency settings, particularly when RT-PCR is not available. Understanding CT findings and severity can aid in guiding patient management and anticipating clinical deterioration.

Conclusion

Chest CT imaging is a valuable adjunct in the diagnosis and management of COVID-19, especially in resource-limited settings. Its role in early detection and severity assessment is critical for effective patient care.